APO RESEARCH · REPORT
Large Volume Wearable Injectors
Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.
Product & engineering
Understand the product.
Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.
Selected research
Industry Research
Large Volume Wearable Injectors Industry Research Report 2026
Market perspective
Large Volume Wearable Injectors, also known as bolus injectors or non-insulin patch pumps, are drug delivery devices that have above 1 ml capacity of injectable volume. These devices can offer a range of benefits to patients, for example, to make administration more convenient and reduce patient suffering.
The major players in global Large Volume Wearable Injectors market include Unilife Corporation, BD Medical, etc. The top 2 players occupy about 45% shares of the global market. North America is the main market, and occupies about 70% of the global market. Electronical Injectors is the main type, with a share about 70%. Auto-immune Treatment is the main application, which holds a share about 40%.
Report Scope
Read the full market overview
This report quantifies the global Large Volume Wearable Injectors market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Large Volume Wearable Injectors Market by Company
West Pharmaceuticals
Unilife Corporation
CeQur
Sensile Medical AG
BD Medical
Enable Injections
Roche Laboratories
scPharmaceuticals
SteadyMed Therapeutics
Johnson & Johnson
Large Volume Wearable Injectors Segment by Type
Electronical Injectors
Mechanical Injectors
Others
Large Volume Wearable Injectors Segment by Application
Cancer Treatment
Auto-immune Treatment
Blood Disorders Treatment
Others
Large Volume Wearable Injectors Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Large Volume Wearable Injectors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Large Volume Wearable Injectors and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Large Volume Wearable Injectors.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Large Volume Wearable Injectors manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Large Volume Wearable Injectors by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Large Volume Wearable Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Electronical Injectors
- Mechanical Injectors
- Others
Applications
- Cancer Treatment
- Auto-immune Treatment
- Blood Disorders Treatment
- Others
Companies covered
- West Pharmaceuticals
- Unilife Corporation
- CeQur
- Sensile Medical AG
- BD Medical
- Enable Injections
- Roche Laboratories
- scPharmaceuticals
- SteadyMed Therapeutics
- Johnson & Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Large Volume Wearable Injectors Market Size (2021-2032)
- 2.2.2 Global Large Volume Wearable Injectors Sales (2021-2032)
- 2.2.3 Global Large Volume Wearable Injectors Market Average Price (2021-2032)
- 2.3 Large Volume Wearable Injectors by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Electronical Injectors
- 2.3.3 Mechanical Injectors
- 2.3.4 Others
- 2.4 Large Volume Wearable Injectors by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Cancer Treatment
- 2.4.3 Auto-immune Treatment
- 2.4.4 Blood Disorders Treatment
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Large Volume Wearable Injectors Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Large Volume Wearable Injectors Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Large Volume Wearable Injectors Revenue of Manufacturers (2021-2026)
- 3.4 Global Large Volume Wearable Injectors Average Price by Manufacturers (2021-2026)
- 3.5 Global Large Volume Wearable Injectors Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Large Volume Wearable Injectors, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Large Volume Wearable Injectors, Product Type & Application
- 3.8 Global Manufacturers of Large Volume Wearable Injectors, Established Date
- 3.9 Global Large Volume Wearable Injectors Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 West Pharmaceuticals
- 4.1.1 West Pharmaceuticals Company Information
- 4.1.2 West Pharmaceuticals Business Overview
- 4.1.3 West Pharmaceuticals Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 West Pharmaceuticals Large Volume Wearable Injectors Product Portfolio
- 4.1.5 West Pharmaceuticals Recent Developments
- 4.2 Unilife Corporation
- 4.2.1 Unilife Corporation Company Information
- 4.2.2 Unilife Corporation Business Overview
- 4.2.3 Unilife Corporation Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Unilife Corporation Large Volume Wearable Injectors Product Portfolio
- 4.2.5 Unilife Corporation Recent Developments
- 4.3 CeQur
- 4.3.1 CeQur Company Information
- 4.3.2 CeQur Business Overview
- 4.3.3 CeQur Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 CeQur Large Volume Wearable Injectors Product Portfolio
- 4.3.5 CeQur Recent Developments
- 4.4 Sensile Medical AG
- 4.4.1 Sensile Medical AG Company Information
- 4.4.2 Sensile Medical AG Business Overview
- 4.4.3 Sensile Medical AG Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sensile Medical AG Large Volume Wearable Injectors Product Portfolio
- 4.4.5 Sensile Medical AG Recent Developments
- 4.5 BD Medical
- 4.5.1 BD Medical Company Information
- 4.5.2 BD Medical Business Overview
- 4.5.3 BD Medical Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 BD Medical Large Volume Wearable Injectors Product Portfolio
- 4.5.5 BD Medical Recent Developments
- 4.6 Enable Injections
- 4.6.1 Enable Injections Company Information
- 4.6.2 Enable Injections Business Overview
- 4.6.3 Enable Injections Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Enable Injections Large Volume Wearable Injectors Product Portfolio
- 4.6.5 Enable Injections Recent Developments
- 4.7 Roche Laboratories
- 4.7.1 Roche Laboratories Company Information
- 4.7.2 Roche Laboratories Business Overview
- 4.7.3 Roche Laboratories Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Roche Laboratories Large Volume Wearable Injectors Product Portfolio
- 4.7.5 Roche Laboratories Recent Developments
- 4.8 scPharmaceuticals
- 4.8.1 scPharmaceuticals Company Information
- 4.8.2 scPharmaceuticals Business Overview
- 4.8.3 scPharmaceuticals Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 scPharmaceuticals Large Volume Wearable Injectors Product Portfolio
- 4.8.5 scPharmaceuticals Recent Developments
- 4.9 SteadyMed Therapeutics
- 4.9.1 SteadyMed Therapeutics Company Information
- 4.9.2 SteadyMed Therapeutics Business Overview
- 4.9.3 SteadyMed Therapeutics Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 SteadyMed Therapeutics Large Volume Wearable Injectors Product Portfolio
- 4.9.5 SteadyMed Therapeutics Recent Developments
- 4.10 Johnson & Johnson
- 4.10.1 Johnson & Johnson Company Information
- 4.10.2 Johnson & Johnson Business Overview
- 4.10.3 Johnson & Johnson Large Volume Wearable Injectors Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Johnson & Johnson Large Volume Wearable Injectors Product Portfolio
- 4.10.5 Johnson & Johnson Recent Developments
5 Global Large Volume Wearable Injectors Market Scenario by Region
- 5.1 Global Large Volume Wearable Injectors Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Large Volume Wearable Injectors Sales by Region: 2021-2032
- 5.2.1 Global Large Volume Wearable Injectors Sales by Region: 2021-2026
- 5.2.2 Global Large Volume Wearable Injectors Sales by Region: 2027-2032
- 5.3 Global Large Volume Wearable Injectors Revenue by Region: 2021-2032
- 5.3.1 Global Large Volume Wearable Injectors Revenue by Region: 2021-2026
- 5.3.2 Global Large Volume Wearable Injectors Revenue by Region: 2027-2032
- 5.4 North America Large Volume Wearable Injectors Market Facts & Figures by Country
- 5.4.1 North America Large Volume Wearable Injectors Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Large Volume Wearable Injectors Sales by Country (2021-2032)
- 5.4.3 North America Large Volume Wearable Injectors Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Large Volume Wearable Injectors Market Facts & Figures by Country
- 5.5.1 Europe Large Volume Wearable Injectors Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Large Volume Wearable Injectors Sales by Country (2021-2032)
- 5.5.3 Europe Large Volume Wearable Injectors Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Large Volume Wearable Injectors Market Facts & Figures by Country
- 5.6.1 Asia Pacific Large Volume Wearable Injectors Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Large Volume Wearable Injectors Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Large Volume Wearable Injectors Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Large Volume Wearable Injectors Market Facts & Figures by Country
- 5.7.1 South America Large Volume Wearable Injectors Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Large Volume Wearable Injectors Sales by Country (2021-2032)
- 5.7.3 South America Large Volume Wearable Injectors Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Large Volume Wearable Injectors Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Large Volume Wearable Injectors Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Large Volume Wearable Injectors Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Large Volume Wearable Injectors Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Large Volume Wearable Injectors Sales by Type (2021-2032)
- 6.1.1 Global Large Volume Wearable Injectors Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Large Volume Wearable Injectors Sales Market Share by Type (2021-2032)
- 6.2 Global Large Volume Wearable Injectors Revenue by Type (2021-2032)
- 6.2.1 Global Large Volume Wearable Injectors Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Large Volume Wearable Injectors Revenue Market Share by Type (2021-2032)
- 6.3 Global Large Volume Wearable Injectors Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Large Volume Wearable Injectors Sales by Application (2021-2032)
- 7.1.1 Global Large Volume Wearable Injectors Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Large Volume Wearable Injectors Sales Market Share by Application (2021-2032)
- 7.2 Global Large Volume Wearable Injectors Revenue by Application (2021-2032)
- 7.2.1 Global Large Volume Wearable Injectors Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Large Volume Wearable Injectors Revenue Market Share by Application (2021-2032)
- 7.3 Global Large Volume Wearable Injectors Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Large Volume Wearable Injectors Value Chain Analysis
- 8.1.1 Large Volume Wearable Injectors Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Large Volume Wearable Injectors Production Mode & Process
- 8.2 Large Volume Wearable Injectors Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Large Volume Wearable Injectors Distributors
- 8.2.3 Large Volume Wearable Injectors Customers
9 Global Large Volume Wearable Injectors Analyzing Market Dynamics
- 9.1 Large Volume Wearable Injectors Industry Trends
- 9.2 Large Volume Wearable Injectors Industry Drivers
- 9.3 Large Volume Wearable Injectors Industry Opportunities and Challenges
- 9.4 Large Volume Wearable Injectors Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst